Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis.
Terashi
A
A
Second Department of Internal Medicine, Daiichi Hospital, Nippon Medical School, Tokyo, Japan.
Kobayashi
Y
Y
Katayama
Y
Y
Inamura
K
K
Kazama
M
M
Abe
T
T
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D004311:Double-Blind Method; D004734:Energy Metabolism; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy*; D051381:Rats; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator